IHS Chemical Week

World News and Views :: Projects

Evonik advances biotech investments

7:04 AM MDT | October 9, 2012 | Sotirios Frantzanas

Evonik says that it plans to continue expanding its commitment to biotech as explores opportunities for profitable growth in a range of business areas. Biotech gives "Evonik's growth strategy a stronger focus on sustainable development. In the health and nutrition business unit alone we are hoping for sales of €1 billion ($1.29 billion) over the medium term for products made using biotech," says Patrik Wohlhauser, member of Evonik's executive board. Evonik will be investing about €350 million by 2014 to expand its Biolys business, an amino...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa